MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

MIMEDX GROUP, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$4.38−0.05 (-1.13%)

Close on Oct 19, 2026

Market cap: $647.35M
P/E (TTM): 109.5
Dividend yield: –

MIMEDX GROUP, INC. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Depreciation & Amortization	15	6.04	3.43	–	–	–	–	–	–	–	–	–	–	–	–	–
Stock-Based Compensation	16	17	17	11	14	15	12	15	21	18	17	11	6.01	2.54	1.66	1.00
Deferred Income Taxes	8.71	12	-41	0	0	0	0	26	-27	-5.38	-15	0	0	–	–	–
Change in Accounts Receivable	-26	-2.55	-12	-5.94	-11	-3.10	-11	0	-0.48	0.07	-27	-11	-8.44	-5.76	-1.21	-0.16
Change in Inventory	-1.53	-2.36	-7.84	-1.79	-1.41	-1.26	6.88	-6.52	2.75	-0.90	-2.33	-1.25	-0.86	-2.31	-0.25	-0.08
Change in Accounts Payable	2.12	-1.41	0.78	0.84	-0.16	0.18	-6.17	6.59	-1.32	-3.48	3.14	1.29	1.21	-0.08	0.73	0.22
Operating Cash Flow	74	66	27	-18	-1.98	-30	-39	36	63	24	19	17	-0.28	-3.33	-6.66	-8.16
Capital Expenditures	–	–	-1.99	-1.51	-3.22	–	–	–	–	–	–	–	–	–	–	–
Acquisitions	-3.76	-7.86	0	0	–	–	–	0	0	-7.63	0	0	0	0	-0.47	0
Sale of Property, Plant & Equipment	–	–	0	0.02	0	0	0	0.03	0	0	–	–	–	–	–	–
Purchase of Investments	–	–	–	–	–	–	–	–	–	–	6.00	-9.00	0	0	–	–
Other Investing Activities	-2.09	-0.04	-0.17	-1.15	–	–	–	–	–	–	–	–	–	–	–	–
Investing Cash Flow	-6.89	-9.58	-2.16	-2.66	-3.40	-4.56	0.50	-9.22	-5.40	-12	-0.68	-12	-3.03	-0.64	-0.70	-0.15
Share Repurchases	0	0	-9.52	0	0	-0.90	0	-7.60	-68	-10	-40	–	–	–	–	–
Taxes Paid on Share-Based Awards	-3.12	-2.64	0	-1.19	-4.75	-2.33	-1.47	-4.91	-4.08	-1.17	0	0	–	–	–	–
Other Financing Activities	0	-0.06	-0.05	-0.04	–	–	–	–	–	–	–	–	–	–	–	–
Financing Cash Flow	-5.41	-34	-8.57	-0.58	-3.35	62	63	-8.93	-60	-8.15	-36	-2.15	41	6.61	10	7.00
Net Change in Cash	62	22	16	-21	-8.73	27	24	18	-2.85	4.02	-18	2.50	37	2.64	2.77	-1.31
Free Cash Flow	–	–	25	-19	-5.20	–	–	–	–	–	–	–	–	–	–	–
Income Taxes Paid	8.51	3.25	-0.55	0.18	0.17	0.21	0.31	0.86	13	0.64	2.29	0.38	0.06	0	0	0
Interest Paid	1.25	2.70	6.03	4.57	4.33	7.46	4.33	0.20	0.13	0.16	0.09	0.05	0.04	0.01	0.02	0.01

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 78.8%
Operating margin: 2.5%
Net margin: 1.8%
Return on equity, FY2025: 21.6%

Financial strength

Current ratio: 5.33
Debt to equity: 0.08
Debt to assets: 6.1%
Cash to current liabilities: 352.8%

Valuation

P/E ratio: 109.5
Price to sales: 1.82
Price to book: 3.00
Dividend yield: –